☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - April 2012

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Fampridine (Fampyra®) has been rejected for use to improve walking in adult patients with multiple sclerosis with walking disability. The manufacturer failed to make a submission. The manufacturer already recommends that use is restricted to prescription and supervision by physicians experienced in the management of multiple sclerosis.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - April 2012' by emailShare 'SMC Update - April 2012' on FacebookShare 'SMC Update - April 2012' on TwitterShare 'SMC Update - April 2012' on LinkedInShare 'SMC Update - April 2012' on reddit


No Comments to “SMC Update - April 2012”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.